Literature DB >> 17718969

Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases.

Y Tang1, R R Taylor, M V Gonzalez, A L Lewis, P W Stratford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17718969     DOI： 10.1016/j.jconrel.2006.09.047

Source DB:  PubMed          Journal:  J Control Release        ISSN： 0168-3659            Impact factor:   9.776


× No keyword cloud information.
  16 in total

1.  Chemoembolization with drug-eluting beads complicated by intrahepatic biloma.

Authors:  Michael Naumann; Richard Bonsall; Ramona Gupta
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

2.  Quantification of irinotecan, SN38, and SN38G in human and porcine plasma by ultra high-performance liquid chromatography-tandem mass spectrometry and its application to hepatic chemoembolization.

Authors:  Xiaohong Chen; Cody J Peer; Raul Alfaro; Tian Tian; Shawn D Spencer; William D Figg
Journal:  J Pharm Biomed Anal       Date:  2012-01-16       Impact factor: 3.935

Review 3.  Transcatheter embolization therapy in liver cancer: an update of clinical evidences.

Authors:  Yì-Xiáng J Wáng; Thierry De Baere; Jean-Marc Idée; Sébastien Ballet
Journal:  Chin J Cancer Res       Date:  2015-04       Impact factor: 5.087

Review 4.  Regional hepatic therapies: an important component in the management of colorectal cancer liver metastases.

Authors:  Abdul Saied; Steven C Katz; N Joseph Espat
Journal:  Hepatobiliary Surg Nutr       Date:  2013-04       Impact factor: 7.293

5.  Synthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolization.

Authors:  Ayele H Negussie; Matthew R Dreher; Carmen Gacchina Johnson; Yiqing Tang; Andrew L Lewis; Gert Storm; Karun V Sharma; Bradford J Wood
Journal:  J Mater Sci Mater Med       Date:  2015-06-24       Impact factor: 3.896

6.  Feasibility, safety and pharmacokinetic study of hepatic administration of drug-eluting beads loaded with irinotecan (DEBIRI) followed by intravenous administration of irinotecan in a porcine model.

Authors:  Andrew L Lewis; Rachel R Holden; S Ting Chung; Peter Czuczman; Timothy Kuchel; John Finnie; Susan Porter; David Foster
Journal:  J Mater Sci Mater Med       Date:  2012-09-27       Impact factor: 3.896

7.  Locoregional therapy and systemic cetuximab to treat colorectal liver metastases.

Authors:  Giammaria Fiorentini; Camillo Aliberti; Donatella Sarti; Paolo Coschiera; Massimo Tilli; Luca Mulazzani; Paolo Giordani; Francesco Graziano; Alfonso Marqués Gonzalez; Raul García Marcos; Fernando Gómez Mugnoz; Maurizio Cantore; Stefano Ricci; Vincenzo Catalano; Andrea Mambrini
Journal:  World J Gastrointest Oncol       Date:  2015-06-15

8.  Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study.

Authors:  Matthew Bower; Tiffany Metzger; Ken Robbins; Dana Tomalty; Vlatimil Válek; Jean Boudný; Tomas Andrasina; Cliff Tatum; Robert C G Martin
Journal:  HPB (Oxford)       Date:  2010-02       Impact factor: 3.647

9.  Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report.

Authors:  Robert Cg Martin; Ken Robbins; Dana Tomalty; Ryan O'Hara; Petar Bosnjakovic; Radek Padr; Miloslav Rocek; Frantisek Slauf; Alexander Scupchenko; Cliff Tatum
Journal:  World J Surg Oncol       Date:  2009-11-03       Impact factor: 2.754

10.  Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry.

Authors:  Robert C G Martin; Jonathan Joshi; Ken Robbins; Dana Tomalty; Ryan O'Hara; Cliff Tatum
Journal:  J Oncol       Date:  2009-10-29       Impact factor: 4.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.